A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
- 1 December 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 82 (6) , 1954-1961
- https://doi.org/10.1161/01.cir.82.6.1954
Abstract
We performed a prospective, randomized, double-blind, crossover study to compare the efficacy and safety of vasodilation with the calcium entry blocker nifedipine with that of isosorbide dinitrate (ISDN) and their combination as treatment for heart failure. Twenty-eight patients with New York Heart Association Functional class II or III chronic heart failure due to left ventricular systolic dysfunction were studied. All patients were maintained on a constant dose of digitalis and diuretics throughout the study. Eight weeks of therapy with nifedipine alone or in combination with ISDN resulted in a significantly higher incidence of heart failure deterioration necessitating hospitalizations and/or additional diuretics. Twenty-four percent of patients required hospitalization during nifedipine therapy and 26% required hospitalization during nifedipine-ISDN combination therapy in comparison to 0% requiring hospitalization during ISDN therapy alone. The total number of heart failure-worsening episodes was nine among patients on nifedipine, three among patients on ISDN (p less than 0.09 versus nifedipine), and 21 among patients on nifedipine-ISDN combination (p less than 0.001 versus nifedipine, p less than 0.0001 versus ISDN). Premature discontinuation of drug administration due to clinical deterioration or other side effects occurred in 29% of patients during nifedipine therapy, 5% of patients during ISDN therapy (p = 0.05 versus nifedipine), and 19% of patients during the combination therapy. A comparison of eight patients who demonstrated clinical deterioration on nifedipine with the remainder of the patients demonstrated no significant difference in left ventricular ejection fraction (0.24 +/- 0.06 versus 0.23 +/- 0.07) or maximal oxygen uptake during exercise (13 +/- 3 versus 14 +/- 2 ml/kg/min).(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 36 references indexed in Scilit:
- Are nitrates effective in the treatment of chronic heart failure? Antagonist's viewpointThe American Journal of Cardiology, 1990
- Characterization of the Dose—Concentration‐Dependent Hemodynamic Effects of Nifedipine in Heart FailureThe Journal of Clinical Pharmacology, 1987
- Effect of Intervals between Doses on the Development of Tolerance to Isosorbide DinitrateNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failureAmerican Heart Journal, 1986
- Nifedipine in heart failureInternational Journal of Cardiology, 1984
- Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamineThe American Journal of Cardiology, 1984
- Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failureAmerican Heart Journal, 1983
- Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placeboAmerican Heart Journal, 1982
- Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart FailureNew England Journal of Medicine, 1982